Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Income from Non-Controlling Interests (2016)

Kiora Pharmaceuticals (KPRX) has disclosed Income from Non-Controlling Interests for 2 consecutive years, with -$1.51 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Income from Non-Controlling Interests fell 100.0% year-over-year to -$1.51, compared with a TTM value of -$1.51 through Dec 2016, down 100.01%, and an annual FY2017 reading of -$0.93, up 38.41% over the prior year.
  • Income from Non-Controlling Interests was -$1.51 for Q4 2016 at Kiora Pharmaceuticals, down from $32967.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $32967.0 in Q4 2015 and bottomed at -$5177.0 in Q1 2015.